Pyrexia, commonly known as fever, is a prevalent symptom in clinical practice. It signifies an underlying pathophysiological process, often an infection or inflammation. Understanding its mechanisms, diagnostic strategies, and management principles is crucial for effective patient care.
Fever is a complex response to pyrogens that reset the hypothalamic thermoregulatory center. Pyrogens can be exogenous, like microbial toxins, or endogenous, such as interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha). These cytokines trigger prostaglandin E2 (PGE2) production, leading to a rise in the set-point temperature.
Thorough history and physical examination form the cornerstone of fever diagnosis. History should include recent travel, exposures, medications, and immunization status. Fever patterns can provide clues to the underlying cause. Laboratory investigations should be guided by clinical suspicion. In cases of fever of unknown origin (FUO), advanced imaging and invasive procedures might be necessary.
Fever management should be tailored to the patient's condition and the underlying cause. Antipyretics, such as acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), are commonly used. However, they should be used judiciously, considering their side effects. In some cases, fever can serve as a beneficial host response, and its suppression may not always be desirable.
In pediatric and geriatric populations, fever can present differently and can have different implications. In children, fever is often higher and can cause febrile seizures. In the elderly, fever response may be blunted, making diagnosis challenging. These populations may require a more cautious approach.
Pyrexia is a common but complex clinical phenomenon. A systematic approach to its diagnosis and management, considering the patient's individual circumstances and the potential benefits and harms of fever suppression, is necessary for optimal patient care.
1.
A US health panel advises starting mammograms at age 40 rather than 50.
2.
TULSA Is Effective in Long-Term Prostate Cancer Control.
3.
J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79
4.
In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".
5.
How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma
1.
Molecular Matching for Individualized Blood-Disorder Therapy
2.
Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment
3.
Drug Safety Surveillance of Long-Term Medication Effects in Cancer Survivorship
4.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
5.
Early Diagnosis of Lung Cancer Through Emerging Biomarkers
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- The Incidence of Cancer in Men
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation